Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.

Miermont AM, Parrish AR, Furth PA.

Carcinogenesis. 2010 Jun;31(6):1124-31. doi: 10.1093/carcin/bgq048. Epub 2010 Feb 24.

2.

Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.

Ting AY, Kimler BF, Fabian CJ, Petroff BK.

Carcinogenesis. 2007 Jan;28(1):130-5. Epub 2006 Aug 3.

PMID:
16891317
3.
4.

Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.

Jones LP, Tilli MT, Assefnia S, Torre K, Halama ED, Parrish A, Rosen EM, Furth PA.

Oncogene. 2008 Jan 31;27(6):794-802. Epub 2007 Jul 23.

5.

Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer.

Blanco-Aparicio C, Pérez-Gallego L, Pequeño B, Leal JF, Renner O, Carnero A.

Carcinogenesis. 2007 Mar;28(3):584-94. Epub 2006 Oct 17.

PMID:
17050554
6.

Differential roles of ERα and ERβ in normal and neoplastic development in the mouse mammary gland.

Mehta RG, Hawthorne M, Mehta RR, Torres KE, Peng X, McCormick DL, Kopelovich L.

PLoS One. 2014 Nov 18;9(11):e113175. doi: 10.1371/journal.pone.0113175. eCollection 2014.

7.

Possible role of Stat5a in rat mammary gland carcinogenesis.

Shan L, Yu M, Clark BD, Snyderwine EG.

Breast Cancer Res Treat. 2004 Dec;88(3):263-72.

PMID:
15609129
8.

An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats.

Cheung SY, Yuen MT, Choi HL, Cheng HK, Huang Y, Chen S, Chan FL.

Int J Oncol. 2003 Jun;22(6):1383-95.

PMID:
12739009
9.

Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse.

Santos SJ, Haslam SZ, Conrad SE.

Endocrinology. 2010 Jun;151(6):2876-85. doi: 10.1210/en.2009-1282. Epub 2010 Apr 14.

10.

Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice.

Jerry DJ, Butel JS, Donehower LA, Paulson EJ, Cochran C, Wiseman RW, Medina D.

Mol Carcinog. 1994 Mar;9(3):175-83.

PMID:
8142019
11.

Comparison of increased aromatase versus ERα in the generation of mammary hyperplasia and cancer.

Díaz-Cruz ES, Sugimoto Y, Gallicano GI, Brueggemeier RW, Furth PA.

Cancer Res. 2011 Aug 15;71(16):5477-87. doi: 10.1158/0008-5472.CAN-10-4652.

13.

Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.

Simanainen U, Gao YR, Walters KA, Watson G, Desai R, Jimenez M, Handelsman DJ.

Horm Cancer. 2012 Jun;3(3):113-24. doi: 10.1007/s12672-012-0107-9.

PMID:
22370991
15.

Loss of Stat5a delays mammary cancer progression in a mouse model.

Ren S, Cai HR, Li M, Furth PA.

Oncogene. 2002 Jun 20;21(27):4335-9.

17.

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.

Arendt LM, Rugowski DE, Grafwallner-Huseth TA, Garcia-Barchino MJ, Rui H, Schuler LA.

Breast Cancer Res. 2011 Jan 28;13(1):R11. doi: 10.1186/bcr2819.

18.

cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.

Shan L, He M, Yu M, Qiu C, Lee NH, Liu ET, Snyderwine EG.

Carcinogenesis. 2002 Oct;23(10):1561-8.

PMID:
12376462
19.

Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function.

Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW.

Cancer Res. 1999 Sep 1;59(17):4276-84.

20.

Supplemental Content

Support Center